SLU-PP-332 500MCG x 50 Oral Tablets – ( Certificate of analysis, second image )

Description

SLU-PP-332 500MCG Oral Tablets

SLU-PP-332 is a potent and selective PPARδ agonist designed for advanced research into metabolic regulation, endurance optimization, and oxidative energy pathways. In this oral tablet format, SLU-PP-332 offers consistent, precise dosing for extended experimental protocols, allowing researchers to investigate its effects on fatty acid oxidation, mitochondrial efficiency, and metabolic flexibility under controlled laboratory conditions.

By selectively activating PPARδ, SLU-PP-332 enables focused studies on lipid metabolism and oxidative performance without impacting unrelated receptor pathways. Its predictable biochemical profile and receptor specificity make it a valuable tool for researchers examining endurance-related performance biology and energy system adaptation.

This premium-grade formulation contains 500MCG per tablet, with 50 tablets per bottle, manufactured to exacting standards and verified through third-party testing for purity and potency. All bottles are securely sealed in tamper-evident packaging to ensure product integrity from production to delivery.

Continue your advanced peptide research at: True North Performance